Rybelsus (Oral Semaglutide) – Weight Loss Without Injections

What Is Rybelsus?

Rybelsus (generic name: oral semaglutide) is the world’s first oral GLP-1 receptor agonist. It uses the same active ingredient as injectable Ozempic and Wegovy (semaglutide), made available in tablet form through a special absorption enhancer (SNAC). It is a genuinely innovative medication.

Taken just once a day in the morning on an empty stomach. Particularly suitable for those who are reluctant to start injections or who are beginning GLP-1 therapy for the first time.

Three Key Features of Rybelsus

Who Is This Suitable For?

• Those who dislike injections and want to start GLP-1 treatment with a tablet
• Those aiming for moderate weight loss of around 5 kg
• Those with diabetes or pre-diabetes who want to manage both blood sugar and body weight simultaneously
• Those who have an established daily medication routine
• Those who want to try GLP-1 therapy as an introduction before considering injectables

Who Cannot Use This Medication?

• Those with a history of pancreatitis
• Those with a personal or family history of medullary thyroid carcinoma or MEN2
• Those with severe gastrointestinal disorders (e.g. gastroparesis)
• Those who are pregnant, planning to become pregnant, or breastfeeding
• Those with a BMI below 18.5

Common Side Effects

Gastrointestinal symptoms are the most common. Most resolve within 2–4 weeks after starting. We can prescribe anti-nausea medication if needed.

Side Effect	Frequency	Management
Nausea	~15%	Small frequent meals; anti-nausea medication
Diarrhea	~11%	Hydration; intestinal regulators
Constipation	~9%	Hydration, fiber, laxatives
Decreased appetite	~10–15%	Observation (also a therapeutic effect)
Headache / dizziness	~5–10%	Observation
Acute pancreatitis (rare)	<0.1%	Seek immediate medical attention for severe upper/back pain

Important Instructions for Taking Rybelsus

How you take Rybelsus directly affects its effectiveness. Please follow these instructions carefully:

• Take immediately upon waking, on an empty stomach (at least 30 minutes before eating)
• Use no more than approx. 120 mL of water (about half a glass) to swallow the tablet
• Avoid food, drink, and other medications for 30 minutes after taking
• Swallow the tablet whole — do not crush or chew

Pricing (Tax included, shipping extra)

Shipping: ¥1,100–¥3,300 / No returns / Payment: credit card, bank transfer (Wise accepted), or cash

※ The first 4 weeks start at 3mg. 100 tablets = approx. 3–4 months (3mg) / approx. 1.5 months (7mg) / approx. 1 month (14mg)

Consultation Flow

※ Customs certificates for returning travelers are available. ※ International shipping not available.

Frequently Asked Questions

Q. Is health insurance accepted?

When used for weight loss without a diagnosis of diabetes, treatment is self-pay (private). Patients diagnosed with diabetes may be eligible for insurance coverage.

Q. How much weight can I expect to lose?

Clinical trials show an average of 3–4 kg (approximately 4–5% of body weight) reduction when taking 14mg for 6 months to 1 year. Most patients notice results at 7mg or above.

Q. How does Rybelsus compare to injectable GLP-1 medications?

Even though both use semaglutide, the injectable (Wegovy) achieves greater weight loss (avg. ~15%). Rybelsus delivers approximately 4–5%, but offers the significant advantage of no injections. For those seeking stronger results, we can discuss stepping up to Wegovy or Mounjaro.

Q. Why must Rybelsus be taken on an empty stomach?

Taking it with food significantly reduces absorption and effectiveness. Taking it on an empty stomach with a small amount of water (approx. 120 mL), then waiting 30–60 minutes before eating, maximizes the drug’s efficacy.

Q. Can international patients receive treatment?

Yes. English support is available. We can also issue a medical certificate for customs declaration upon returning to your home country.